Today is: April 13, 2011

Evaluate Your Case Today

Calcagno & Associates

900 South Avenue, 3rd Floor
Staten Island, NY, 10314
Phone: 1-800-WE-FIGHT
             (718) 568-3585

By appointment only

Battery Place
New York, NY, 10004
Phone: (800) 933-4448

Grand Concourse Bronx, NY, 10451 Phone: (718) 933-4448

Bay Parkway Brooklyn, NY, 11214 Phone: (800) 487-6837

Name (First & Last)
DOB (Victims Date of Birth)


Email Address





Message about your case

MRI Agent Gadolinium

MRI Agent Gadolinium Linked to Dangerous Skin Disorder in Kidney Patients

In MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiography) scans, patients may be injected with a gadolinium-based contrast agent which can lead to a life-threatening skin disorder in kidney patients. Because kidney failure patients may be unable to filter the gadolinium out of their systems, a recently identified disorder called Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermotherapy (NSF/NFD) may develop. The FDA has warned against utilizing gadolinium-based contrast agents in kidney patients unless absolutely necessary, and if they are used, that the patient be put on dialysis immediately after the procedure. It is estimated that there are 200-500 cases of NSF / NFD worldwide. The FDA has received reports of 90 cases of NSF / NFD in kidney patients up until December, 2006.

Gadolinium-containing Contrast Agents

Following are the major gadolinium-based contrast agents used for MRI and MRA procedures.

Kidney Patients Have Legal Rights


Return to Defective Drugs Listing


Keywords | Articles | Locations | Coupons |